miR-96 |
Oncogene |
Hepatocellular carcinoma |
Increases proliferation and colony formation |
FOXO1, FOXO3a
|
[2] |
miR-96 |
Oncogene |
Prostate cancer |
Inhibits zinc uptake |
ZIP1, ZIP3, ZIP7, ZIP9, ZnT1, ZnT7
|
[3] |
miR-182 |
miR-183 |
miR-96 |
Oncogene |
Medullo-blastoma |
Inhibits apoptosis, destroys DNA repair, promotes cell migration |
See reference
|
[4] |
miR-182 |
miR-183 |
miR-96 |
Oncogene |
Breast cancer |
Induces proliferation |
FOXO3a
|
[5] |
miR-96 |
Oncogene |
Breast cancer |
Increases cell number |
FOXO1
|
[6] |
miR-182 |
miR-182 |
Oncogene |
Glioma |
Promotes glioma cell aggression |
CYLD
|
[7] |
miR-182 |
Oncogene |
Melanoma |
Promotes cell migration and survival |
FOXO3
|
[8] |
miR-183 |
Oncogene |
Synovial sarcoma |
Promotes tumor cell migration |
EGR1
|
[9] |
PTEN
|
miR-183 |
Oncogene |
Hepatocellular carcinoma |
Iinhibits TGF-beta1-induced apoptosis |
PDCD4
|
[10] |
miR-96 |
Tumor suppressor |
Pancreatic cancer |
Decreases cell invasion, migration and tumor growth |
KRAS
|
[11] |
miR-183 |
Tumor suppressor |
Breast cancer |
Inhibits migration |
Ezrin
|
[12] |
miR-183 |
Tumor suppressor |
Osteosarcoma |
Inhibits migration and invasion |
Ezrin
|
[13] |
miR-182 |
Tumor suppressor |
Lung cancer |
Inhibits cancer cell proliferation |
RGS17
|
[14] |